|MAP kinase signalling pathways in cancer|
AS Dhillon, S Hagan, O Rath, W Kolch
Oncogene 26 (22), 3279-3290, 2007
|Reduction of Raf-1 kinase inhibitor protein expression correlates with breast cancer metastasis|
S Hagan, F Al-Mulla, E Mallon, K Oien, R Ferrier, B Gusterson, JJC García, ...
Clinical Cancer Research 11 (20), 7392-7397, 2005
|Reduction in Raf kinase inhibitor protein expression is associated with increased Ras-extracellular signal-regulated kinase signaling in melanoma cell lines|
MM Schuierer, F Bataille, S Hagan, W Kolch, AK Bosserhoff
Cancer research 64 (15), 5186-5192, 2004
|Absence of xenotropic murine leukaemia virus-related virus in UK patients with chronic fatigue syndrome|
HCT Groom, VC Boucherit, K Makinson, E Randal, S Baptista, S Hagan, ...
Retrovirology 7 (1), 10, 2010
|Raf kinase inhibitor protein expression in a survival analysis of colorectal cancer patients|
F Al-Mulla, S Hagan, AI Behbehani, MS Bitar, SS George, JJ Going, ...
Journal of Clinical Oncology 24 (36), 5672-5679, 2006
|Hepatocyte growth factor/scatter factor in the eye|
I Grierson, L Heathcote, P Hiscott, P Hogg, M Briggs, S Hagan
Progress in retinal and eye research 19 (6), 779-802, 2000
|Tear fluid biomarkers in ocular and systemic disease: potential use for predictive, preventive and personalised medicine.|
ESA Hagan S, Martin E
EPMA J 7, 15, 2016
|Raf kinase inhibitor protein: mechanism of loss of expression and association with genomic instability|
F Al-Mulla, S Hagan, W Al-Ali, SP Jacob, AI Behbehani, MS Bitar, A Dallol, ...
Journal of Clinical Pathology 61 (4), 524-529, 2008
|Pathobiology of epiretinal and subretinal membranes: possible roles for the matricellular proteins thrombospondin 1 and osteonectin (SPARC)|
P Hiscott, S Hagan, L Heathcote, CM Sheridan, CP Groenewald, ...
Eye 16 (4), 393-403, 2002
|EPMA position paper in cancer: current overview and future perspectives|
G Grech, X Zhan, BC Yoo, R Bubnov, S Hagan, R Danesi, G Vittadini, ...
EPMA Journal 6 (1), 9, 2015
|Targeted therapies in colorectal cancer—an integrative view by PPPM|
S Hagan, MCM Orr, B Doyle
EPMA Journal 4 (1), 3, 2013
|A gene signature for post-infectious chronic fatigue syndrome|
JW Gow, S Hagan, P Herzyk, C Cannon, PO Behan, A Chaudhuri
BMC medical genomics 2 (1), 1-11, 2009
|Loss of heterozygosity on chromosomes 3, 9, 13, and 17, including the retinoblastoma locus, in uveal melanoma|
AGM Scholes, T Liloglou, P Maloney, S Hagan, J Nunn, P Hiscott, ...
Investigative ophthalmology & visual science 42 (11), 2472-2477, 2001
|Raf kinase inhibitor protein regulation of raf and MAPK signaling|
S Hagan, R Garcia, A Dhillon, W Kolch
Methods in enzymology 407, 248-259, 2006
|Tear fluid biomarker profiling: a review of multiplex bead analysis|
S Hagan, A Tomlinson
The ocular surface 11 (4), 219-235, 2013
|Cultured human retinal pigment epithelial cells differentially express thrombospondin-1,-2,-3, and-4|
JA Carron, P Hiscott, S Hagan, CM Sheridan, R Magee, JA Gallagher
The International Journal of Biochemistry & Cell Biology 32 (11-12), 1137-1142, 2000
|Overexpression of epidermal growth factor receptor restricted to macrophages in uveal melanoma|
AGM Scholes, S Hagan, P Hiscott, BE Damato, I Grierson
Archives of ophthalmology 119 (3), 373-377, 2001
|Mutationally activated K-ras 4A and 4B both mediate lung carcinogenesis|
CE Patek, MJ Arends, WAH Wallace, F Luo, S Hagan, DG Brownstein, ...
Experimental cell research 314 (5), 1105-1114, 2008
|Raf kinase inhibitor protein expression combined with peritoneal involvement and lymphovascular invasion predicts prognosis in D ukes' B colorectal cancer patients|
B Doyle, S Hagan, F Al‐Mulla, L Scott, S Harden, J Paul, H Mulcahy, ...
Histopathology 62 (3), 505-510, 2013
|The role of matricellular proteins thrombospondin-1 and osteonectin during RPE cell migration in proliferative vitreoretinopathy|
CM Sheridan, RM Magee, PS Hiscott, S Hagan, DH Wong, JN McGalliard, ...
Current eye research 25 (5), 279-285, 2002